Trade Summary

3 days ago, Rubinstein Julie, serving as Pres, COO at Adaptive Biotechnologies Corp (ADPT), sold 92,823 shares at $16.09 per share, for a total transaction value of $1,493,428.00. Following this transaction, Rubinstein Julie now holds 575,235 shares of ADPT.

This sale represents a 14.00% decrease in Rubinstein Julie's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Tuesday, March 3, 2026 and publicly disclosed via SEC Form 4 filing on Thursday, March 5, 2026, 2 days after the trade was made.

Adaptive Biotechnologies Corp operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.